GAITHERSBURG, Md.--(BUSINESS WIRE)--GenVec, Inc. (Nasdaq:GNVC), a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines, announced today that it was selected for addition to the NASDAQ Biotechnology Index (NBI), effective as of the market open on Monday, May 21, 2007.
